|
| Vegetable | Clinical effects | Reference |
|
| Resveratrol | (i) Decreases SBP without affecting DBP | [37] |
| (ii) Enhances Ach-mediated vasorelaxation in hypertensive and dyslipidemic pts | [38] |
| (iii) Improves FMD in pts with either metabolic syndrome or previous MI | [39, 40] |
| (iv) Decreases total cholesteroland total and ox-LDL, triglycerides, and ApoB levels in pts with T2DM, CAD, hyperlipidemia, and other CV risk factors | [53, 54] |
| (v) Improves insulin sensitivity in both obese and metabolic syndrome pts | [66, 67] |
| (vi) Improves significantly diastolic function and modestly systolic function in pts with previous MI | [40] |
|
| Brassica oleracea | (i) Reduces total, LDL cholesterol and markers of oxidative stress in smokers and hypercholesterolemic pts | [108, 119] |
| (ii) Improves lipid profiles and ox-LDL/LDL cholesterol ratio in T2DM pts | [132] |
| (iii) Lowers arterial stiffness and central BP in women | [133] |
|
| Curcumin | (i) Decreases both total and LDL cholesterol and increases HDL cholesterol in healthy subjects and in ACS pts | [164, 165] |
| (ii) Increases FMD in postmenopausal women | [168] |
|
| Berberine | (i) Increases both LVEF and exercise capacity and decreases rates of ventricular premature complexes and long-term mortality in HF pts | [199] |
| (ii) Reduces total cholesterol, triglycerides, and LDL cholesterol levels and modestly increases HDL cholesterol in hyperlipidemic and T2DM pts | [203, 205] |
| (iii) Reduces glycated hemoglobin, fasting plasma insulin, postprandial glucose, and fasting plasma glucose in T2DM pts | [204] |
| (iv) Lowers SBP and DBP in hypertensive, T2DM, and hyperlipidemic pts | [206] |
|
